首页> 外文期刊>Critical Reviews in Biomedical Engineering >Bioinspired Engineering for Liver Tissue Regeneration and Development of Bioartificial Liver: A Review
【24h】

Bioinspired Engineering for Liver Tissue Regeneration and Development of Bioartificial Liver: A Review

机译:生物渗透工程肝组织再生和生物肝脏发展:综述

获取原文
获取原文并翻译 | 示例
       

摘要

Patients with advanced liver disease have very high mortality due to associated complications such as hepatic encephalopathy, hepatorenal syndrome, and multiorgan failure. Liver transplant is the only therapeutic option for such patients; however, problems linked to availability, cost, complications, and side effects limit its practical application. The strong potential for hepatic regeneration and recovery has been documented in liver disease, without advance decomposition of the liver. Recently, hepatocyte transplantation was used as an alternative to liver transplantation, but insufficient numbers of functional hepatocytes for therapeutic efficacy limits its use. In addition, extracorporeal liver support systems are a modality for patient management or they can be used as a bridge to a possible liver transplant. But such systems lack clear-cut survival benefits, specifically in advanced liver disease. Due to the limited amount of organ donations and living donor liver transplantation across the globe, novel technologies have been proposed for development of three-dimensional (3D) composite constructs, 3D perfused bioreactors for spheroid culture, liver-on-chip platforms, and bioprinted liver to produce an implantable in vitro liver that can reliably predict in vivo-like tissue responses and suitability for drug toxicity testing. These research fields stand to be game changers in regeneration and repair of liver tissues in patients. This review focuses on novel technologies that are currently used for liver regeneration and production of transplantable liver.
机译:由于肝癌,肝癌综合征等相关并发症,肝病先进的肝病患者具有很高的死亡率。肝移植是此类患者的唯一治疗选择;但是,与可用性,成本,并发症和副作用相关的问题限制了其实际应用。肝脏疾病的肝脏再生和恢复的强潜力已经记录在肝脏疾病中,没有提前分解肝脏。最近,肝细胞移植用作肝移植的替代方案,但对于治疗效率的功能性肝细胞数量不足限制其使用。此外,体外肝脏支持系统是患者管理的模态,或者它们可以用作可能的肝移植的桥梁。但这种系统缺乏清除的生存益处,特别是在先进的肝病中。由于全球的器官捐赠和活体供体肝移植有限,已经提出了用于开发三维(3D)复合构建体,3D灌注生物反应器,用于球形培养,芯片片平台和生物印刷的3D灌注生物反应器肝脏生产可植入的体外肝脏,可可靠地预测体内组织响应和适合药物毒性测试。这些研究领域站在患者肝组织的再生和修复中的游戏变化。本综述重点介绍目前用于肝脏再生和可移植肝脏生产的新技术。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号